BBIO - BridgeBio Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BBIO is currently covered by 13 analysts with an average price target of $50.67. This is a potential upside of $20 (65.21%) from yesterday's end of day stock price of $30.67.

BridgeBio Pharma's activity chart (see below) currently has 98 price targets and 120 ratings on display. The stock rating distribution of BBIO is 98.28% BUY and 1.72% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50.4% with an average time for these price targets to be met of 199.27 days.

Highest price target for BBIO is $95, Lowest price target is $45, average price target is $51.38.

Most recent stock forecast was given by ANUPAM RAMA from JPMORGAN on 24-Mar-2025. First documented stock forecast 22-Jul-2019.

Currently out of the existing stock ratings of BBIO, 57 are a BUY (98.28%), 1 are a HOLD (1.72%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$50

$18.63 (59.39%)

$43

14 days ago
(24-Mar-2025)

10/14 (71.43%)

$12.78 (34.34%)

136

Buy

$52

$20.63 (65.76%)

$48

1 months 17 days ago
(21-Feb-2025)

3/7 (42.86%)

$15.19 (41.27%)

220

Buy

$95

$63.63 (202.84%)

$70

1 months 17 days ago
(21-Feb-2025)

1/9 (11.11%)

$58.19 (158.08%)

244

Buy

$49

$17.63 (56.20%)

$45

1 months 17 days ago
(21-Feb-2025)

1/4 (25%)

$12.19 (33.12%)

50

Buy

$50

$18.63 (59.39%)

$45

3 months 15 days ago
(23-Dec-2024)

0/3 (0%)

$22.23 (80.05%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BBIO (BridgeBio Pharma) average time for price targets to be met?

On average it took 199.27 days on average for the stock forecasts to be realized with a an average price target met ratio 50.4

Which analyst has the current highest performing score on BBIO (BridgeBio Pharma) with a proven track record?

TYLER VAN BUREN

Which analyst has the most public recommendations on BBIO (BridgeBio Pharma)?

Tyler Van Buren works at TD COWEN and has 5 price targets and 3 ratings on BBIO

Which analyst is the currently most bullish on BBIO (BridgeBio Pharma)?

Josh Schimmer with highest potential upside - $63.63

Which analyst is the currently most reserved on BBIO (BridgeBio Pharma)?

Eun Yang with lowest potential downside - -$7.37

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?